Nearly 2 million customers have requested their biological data be deleted from the company database. The District of Columbia and 27 states have sued to block the purchase…
Read MorePharmaceuticals
Federal Agencies Request Public Input on Healthcare Price Transparency
The effort aligns with President Trump’s executive order on healthcare pricing. The Departments of Labor, Health and Human Services (HHS), and the Treasury recently issued a joint Request…
Read MoreFTC Challenges Drug Patents Hindering Generic Competition
The agency renewed efforts to remove over 200 disputed patents from FDA’s Orange Book to promote affordable medication access. The Federal Trade Commission (FTC) recently renewed its challenge…
Read MoreHHS Issues Report from President’s MAHA Commission
The health secretary says policy recommendations will be issued over the next 100 days. The Department of Health and Human Services (HHS) released a preliminary health assessment last…
Read MorePresident Signs Executive Order to Lower Prescription Drug Pricing
He said the U.S. will “no longer tolerate profiteering and price gouging from big pharma.” President Donald Trump signed an Executive Order on Monday to lower prescription drug…
Read MoreU.S. and China Announce Tariff Reduction Amid Trade Negotiations
The 90-day reduction comes after trade officials met in Switzerland. The United States and China issued a joint statement outlining their agreement to reduce retaliatory tariffs for 90…
Read MoreWalgreens Agrees to Settlement Over Illegal Prescription Allegations
The pharmacy was accused of filling “excessive quantities of opioids.” Walgreen Boots Alliance has agreed to an up to $350 million settlement with the Department of Justice (DOJ),…
Read MorePresident Proposes 25% Tariffs on Vehicles, Pharmaceuticals, and Microchips
He encourages foreign companies to bring manufacturing into the United States. President Donald Trump said that his administration would impose new tariffs on foreign-made automobiles, semiconductors, and pharmaceuticals…
Read MoreFederal Court Rules in Favor of Generic Drug Competition in Patent Case
The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read MoreVA Enters Into Development Partnership with Hoth Therapeutics
The biopharmaceutical company will research treatments for obesity and linked health conditions. The Department of Veterans Affairs (VA) recently finalized an agreement with biopharmaceutical company Hoth Therapeutics, which…
Read More